Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney

This publication has 155 references indexed in Scilit:

• Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific Phosphodiesterase
  Biochemical and Biophysical Research Communications, 1998
• A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension
  Life Sciences, 1996
• A New Cyclic Nucleotide Phosphodiesterase Isozyme Expressed in the T-Lymphocyte Cell Lines
  Biochemical and Biophysical Research Communications, 1993
• Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes
  Biochemistry, 1993
• The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells
  International Journal of Immunopharmacology, 1993
• Two Isoforms of cGMP-Inhibited Cyclic Nucleotide Phosphodiesterases in Human Tissues Distinguished by Their Responses to Vesnarinone, a New Cardiotonic Agent
  Biochemical and Biophysical Research Communications, 1993
• Interaction of the catalytic subunit of protein kinase A with the lung type V cyclic GMP phosphodiesterase: Modulation of non-catalytic binding sites
  Biochemical and Biophysical Research Communications, 1992
• Isozymes of cyclic-3′,5′-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells
  Kidney International, 1992
• Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments
  Kidney International, 1980
• Adenyl cyclase and adenosine 3', 5'-cyclic phosphate phosphodiesterase in the receptor tissues of neurohypophysial hormones
  Life Sciences, 1968